Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $35.66 million. The enterprise value is $26.74 million.
| Market Cap | 35.66M |
| Enterprise Value | 26.74M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, after market close.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACXP has 15.84 million shares outstanding. The number of shares has increased by 32.93% in one year.
| Shares Outstanding | 15.84M |
| Shares Change (YoY) | +32.93% |
| Shares Change (QoQ) | +11.79% |
| Owned by Insiders (%) | 15.18% |
| Owned by Institutions (%) | 12.47% |
| Float | 13.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.95 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93, with zero debt.
| Current Ratio | 2.93 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -308.50% and return on invested capital (ROIC) is -267.61%.
| Return on Equity (ROE) | -308.50% |
| Return on Assets (ROA) | -193.30% |
| Return on Capital (ROIC) | -267.61% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.01M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.34% in the last 52 weeks. The beta is -1.78, so ACXP's price volatility has been lower than the market average.
| Beta (1Y) | -1.78 |
| 52-Week Price Change | -28.34% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 2.90 |
| Relative Strength Index (RSI) | 56.99 |
| Average Volume (30 Days) | 76,909 |
Short Selling Information
The latest short interest is 615,451, so 3.88% of the outstanding shares have been sold short.
| Short Interest | 615,451 |
| Short Previous Month | 579,121 |
| Short % of Shares Out | 3.88% |
| Short % of Float | 4.58% |
| Short Ratio (days to cover) | 7.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.05M |
| Pretax Income | -16.05M |
| Net Income | -16.05M |
| EBITDA | -16.05M |
| EBIT | -16.05M |
| Earnings Per Share (EPS) | -$1.18 |
Balance Sheet
The company has $8.92 million in cash and no debt, giving a net cash position of $8.92 million or $0.56 per share.
| Cash & Cash Equivalents | 8.92M |
| Total Debt | n/a |
| Net Cash | 8.92M |
| Net Cash Per Share | $0.56 |
| Equity / Book Value | 6.00M |
| Book Value Per Share | 0.38 |
| Working Capital | 6.00M |
Cash Flow
| Operating Cash Flow | -10.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.93M |
| FCF Per Share | -$0.71 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.93% |
| Shareholder Yield | -32.93% |
| Earnings Yield | -45.01% |
| FCF Yield | -30.65% |
Analyst Forecast
The average price target for ACXP is $12.00, which is 433.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 433.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 29.65% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |